{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:36:01Z","timestamp":1793644561894,"version":"4.5.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/P33955"],"award-info":[{"award-number":["10.55776\/P33955"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/P34036"],"award-info":[{"award-number":["10.55776\/P34036"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/F73"],"award-info":[{"award-number":["10.55776\/F73"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/COE7"],"award-info":[{"award-number":["10.55776\/COE7"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/COE17"],"award-info":[{"award-number":["10.55776\/COE17"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/FG12"],"award-info":[{"award-number":["10.55776\/FG12"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P33955"],"award-info":[{"award-number":["P33955"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P2BSP3_191740"],"award-info":[{"award-number":["P2BSP3_191740"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P400PM_191032"],"award-info":[{"award-number":["P400PM_191032"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The human monoamine transporters (MATs) for serotonin (SERT), dopamine (DAT), and norepinephrine (NET) play a key role in neurotransmission by transporting neurotransmitters from the synaptic cleft back into the neuron. MATs are embedded in the cell membrane\u2019s lipid bilayer, encompassing cholesterol, phospholipids, and sphingolipids as main components. Membrane cholesterol association has been shown for all MATs impacting transporter conformation, substrate affinity, transport velocity, and turnover rates. In the present study, we compared the regulatory impact of cholesterol on the uptake and efflux function, binding affinity, and transporter oligomerization across all three MATs. We observed that cholesterol depletion impairs transporter-mediated uptake in human transporter-transfected HEK293 cells and reduces the binding affinity of all MATs. Electrophysiological investigations in SERT-expressing cells revealed that cholesterol alterations affect the transition of the transporter from the outward to the inward-facing conformation in the presence of substrate. Upon cholesterol depletion, FRET imaging and single molecule microscopy studies indicated altered oligomerization behavior exclusively for SERT. Interestingly, reduction of membrane cholesterol selectively increased amphetamine-induced efflux via SERT, while efflux via DAT and NET was reduced. This effect was diminished in a mutant with reduced PIP\n                    <jats:sub>2<\/jats:sub>\n                    binding capacity. Hence, the increased efflux at SERT due to cholesterol depletion appears to depend on the ability of PIP\n                    <jats:sub>2<\/jats:sub>\n                    to bind to SERT. Thus, we hypothesize that the interaction profile between cholesterol and MATs may fine-tune the transporter functionality and influence MAT-dependent disorders.\n                  <\/jats:p>","DOI":"10.1038\/s41380-025-03201-y","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:58:43Z","timestamp":1756828723000},"page":"963-975","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cell membrane cholesterol affects serotonin transporter efflux due to altered transporter oligomerization"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3069-9732","authenticated-orcid":false,"given":"Deborah","family":"Rudin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0874-4875","authenticated-orcid":false,"given":"Dino","family":"Luethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0518-5791","authenticated-orcid":false,"given":"Marco","family":"Niello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8928-0130","authenticated-orcid":false,"given":"Jae-Won","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Sandtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-0312","authenticated-orcid":false,"given":"Ruth","family":"Birner-Gruenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard J.","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-7444","authenticated-orcid":false,"given":"Harald H.","family":"Sitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"3201_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1124\/pr.108.000869","volume":"63","author":"AS Kristensen","year":"2011","unstructured":"Kristensen AS, Andersen J, J\u00f8rgensen TN, S\u00f8rensen L, Eriksen J, Loland CJ, et al. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev. 2011;63:585\u2013640.","journal-title":"Pharmacol Rev"},{"key":"3201_CR2","doi-asserted-by":"publisher","first-page":"D181","DOI":"10.1093\/nar\/gkj001","volume":"34","author":"MH Saier Jr","year":"2006","unstructured":"Saier MH Jr, Tran CV, Barabote RD. TCDB: the transporter classification database for membrane transport protein analyses and information. Nucleic Acids Res. 2006;34:D181\u20136.","journal-title":"Nucleic Acids Res"},{"key":"3201_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41586-024-07719-z","volume":"632","author":"J Tan","year":"2024","unstructured":"Tan J, Xiao Y, Kong F, Zhang X, Xu H, Zhu A, et al. Molecular basis of human noradrenaline transporter reuptake and inhibition. Nature. 2024;632:921\u20139.","journal-title":"Nature"},{"key":"3201_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","volume":"36","author":"HH Sitte","year":"2015","unstructured":"Sitte HH, Freissmuth M. Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol Sci. 2015;36:41\u201350.","journal-title":"Trends Pharmacol Sci"},{"key":"3201_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrn2059","volume":"8","author":"JA Allen","year":"2007","unstructured":"Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci. 2007;8:128\u201340.","journal-title":"Nat Rev Neurosci"},{"key":"3201_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41580-022-00490-x","volume":"23","author":"Y Posor","year":"2022","unstructured":"Posor Y, Jang W, Haucke V. Phosphoinositides as membrane organizers. Nat Rev Mol Cell Biol. 2022;23:797\u2013816.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3201_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.tibs.2024.01.007","volume":"49","author":"G Pabst","year":"2024","unstructured":"Pabst G, Keller S. Exploring membrane asymmetry and its effects on membrane proteins. Trends Biochem Sci. 2024;49:333\u201345.","journal-title":"Trends Biochem Sci"},{"key":"3201_CR8","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/s41386-018-0133-6","volume":"43","author":"JJ Liu","year":"2018","unstructured":"Liu JJ, Hezghia A, Shaikh SR, Cenido JF, Stark RE, Mann JJ, et al. Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression. Neuropsychopharmacology. 2018;43:2165\u201379.","journal-title":"Neuropsychopharmacology"},{"key":"3201_CR9","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","volume":"50","author":"N Bartke","year":"2009","unstructured":"Bartke N, Hannun YA. Bioactive sphingolipids: metabolism and function. J Lipid Res. 2009;50:S91\u20136.","journal-title":"J Lipid Res"},{"key":"3201_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1091\/mbc.e06-05-0445","volume":"18","author":"D W\u00fcstner","year":"2006","unstructured":"W\u00fcstner D. Plasma membrane sterol distribution resembles the surface topography of living cells. Mol Biol Cell. 2006;18:211\u201328.","journal-title":"Mol Biol Cell"},{"key":"3201_CR11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","volume":"45","author":"JM Dietschy","year":"2004","unstructured":"Dietschy JM, Turley SD. Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004;45:1375\u201397.","journal-title":"J Lipid Res"},{"key":"3201_CR12","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","volume":"294","author":"DH Mauch","year":"2001","unstructured":"Mauch DH, N\u00e4gler K, Schumacher S, G\u00f6ritz C, M\u00fcller EC, Otto A, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001;294:1354\u20137.","journal-title":"Science"},{"key":"3201_CR13","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1021\/acschemneuro.3c00823","volume":"15","author":"LS Kalinichenko","year":"2024","unstructured":"Kalinichenko LS, Kornhuber J, Sinning S, Haase J, M\u00fcller CP. Serotonin Signaling through Lipid Membranes. ACS Chem Neurosci. 2024;15:1298\u2013320.","journal-title":"ACS Chem Neurosci"},{"key":"3201_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature12533","volume":"503","author":"A Penmatsa","year":"2013","unstructured":"Penmatsa A, Wang KH, Gouaux E. X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature. 2013;503:85\u201390.","journal-title":"Nature"},{"key":"3201_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41586-024-07437-6","volume":"630","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yin YL, Dai A, Zhang T, Zhang C, Wu C, et al. Dimerization and antidepressant recognition at noradrenaline transporter. Nature. 2024;630:247\u201354.","journal-title":"Nature"},{"key":"3201_CR16","doi-asserted-by":"publisher","first-page":"19315","DOI":"10.1074\/jbc.M311172200","volume":"279","author":"LD Jayanthi","year":"2004","unstructured":"Jayanthi LD, Samuvel DJ, Ramamoorthy S. Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization. J Biol Chem. 2004;279:19315\u201326.","journal-title":"J Biol Chem"},{"key":"3201_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nature17629","volume":"532","author":"JA Coleman","year":"2016","unstructured":"Coleman JA, Green EM, Gouaux E. X-ray structures and mechanism of the human serotonin transporter. Nature. 2016;532:334\u20139.","journal-title":"Nature"},{"key":"3201_CR18","doi-asserted-by":"publisher","first-page":"32616","DOI":"10.1074\/jbc.M110.150565","volume":"285","author":"WC Hong","year":"2010","unstructured":"Hong WC, Amara SG. Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. J Biol Chem. 2010;285:32616\u201326.","journal-title":"J Biol Chem"},{"key":"3201_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuropharm.2018.01.039","volume":"133","author":"M Morissette","year":"2018","unstructured":"Morissette M, Morin N, Rouillard C, Di Paolo T. Membrane cholesterol removal and replenishment affect rat and monkey brain monoamine transporters. Neuropharmacology. 2018;133:289\u2013306.","journal-title":"Neuropharmacology"},{"key":"3201_CR20","doi-asserted-by":"publisher","first-page":"e1005907","DOI":"10.1371\/journal.pcbi.1005907","volume":"14","author":"T Zeppelin","year":"2018","unstructured":"Zeppelin T, Ladefoged LK, Sinning S, Periole X, Schi\u00f8tt B. A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition. PLoS Comput Biol. 2018;14:e1005907.","journal-title":"PLoS Comput Biol"},{"key":"3201_CR21","doi-asserted-by":"publisher","first-page":"10507","DOI":"10.1021\/bi010730z","volume":"40","author":"SM Scanlon","year":"2001","unstructured":"Scanlon SM, Williams DC, Schloss P. Membrane cholesterol modulates serotonin transporter activity. Biochemistry. 2001;40:10507\u201313.","journal-title":"Biochemistry"},{"key":"3201_CR22","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1074\/jbc.M117.809046","volume":"293","author":"L Laursen","year":"2018","unstructured":"Laursen L, Severinsen K, Kristensen KB, Periole X, Overby M, M\u00fcller HK, et al. Cholesterol binding to a conserved site modulates the conformation, pharmacology, and transport kinetics of the human serotonin transporter. J Biol Chem. 2018;293:3510\u201323.","journal-title":"J Biol Chem"},{"key":"3201_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109387","volume":"225","author":"S Wang","year":"2023","unstructured":"Wang S, Neel AI, Adams KL, Sun H, Jones SR, Howlett AC, et al. Atorvastatin differentially regulates the interactions of cocaine and amphetamine with dopamine transporters. Neuropharmacology. 2023;225:109387.","journal-title":"Neuropharmacology"},{"key":"3201_CR24","doi-asserted-by":"publisher","first-page":"10484","DOI":"10.1021\/bi700429z","volume":"46","author":"EM Adkins","year":"2007","unstructured":"Adkins EM, Samuvel DJ, Fog JU, Eriksen J, Jayanthi LD, Vaegter CB, et al. Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching. Biochemistry. 2007;46:10484\u201397.","journal-title":"Biochemistry"},{"key":"3201_CR25","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/j.1471-4159.2008.05262.x","volume":"105","author":"JD Foster","year":"2008","unstructured":"Foster JD, Adkins SD, Lever JR, Vaughan RA. Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J Neurochem. 2008;105:1683\u201399.","journal-title":"J Neurochem"},{"key":"3201_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nn.2781","volume":"14","author":"ML Cremona","year":"2011","unstructured":"Cremona ML, Matthies HJ, Pau K, Bowton E, Speed N, Lute BJ, et al. Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT. Nat Neurosci. 2011;14:469\u201377.","journal-title":"Nat Neurosci"},{"key":"3201_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-10-65","volume":"10","author":"HJG Matthies","year":"2009","unstructured":"Matthies HJG, Han Q, Shields A, Wright J, Moore JL, Winder DG, et al. Subcellular localization of the antidepressant-sensitive norepinephrine transporter. BMC Neuroscience. 2009;10:65.","journal-title":"BMC Neuroscience"},{"key":"3201_CR28","doi-asserted-by":"publisher","first-page":"38770","DOI":"10.1074\/jbc.M400831200","volume":"279","author":"F Magnani","year":"2004","unstructured":"Magnani F, Tate CG, Wynne S, Williams C, Haase J. Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J Biol Chem. 2004;279:38770\u20138.","journal-title":"J Biol Chem"},{"key":"3201_CR29","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1074\/jbc.M007357200","volume":"276","author":"JA Schmid","year":"2001","unstructured":"Schmid JA, Scholze P, Kudlacek O, Freissmuth M, Singer EA, Sitte HH. Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J Biol Chem. 2001;276:3805\u201310.","journal-title":"J Biol Chem"},{"key":"3201_CR30","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1074\/jbc.M113.531632","volume":"289","author":"A Anderluh","year":"2014","unstructured":"Anderluh A, Klotzsch E, Reismann AWAF, Brameshuber M, Kudlacek O, Newman AH, et al. Single molecule analysis reveals coexistence of stable serotonin transporter monomers and oligomers in the live cell plasma membrane. J Biol Chem. 2014;289:4387\u201394.","journal-title":"J Biol Chem"},{"key":"3201_CR31","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1074\/jbc.RA118.006178","volume":"294","author":"AK Das","year":"2019","unstructured":"Das AK, Kudlacek O, Baumgart F, Jaentsch K, Stockner T, Sitte HH, et al. Dopamine transporter forms stable dimers in the live cell plasma membrane in a phosphatidylinositol 4,5-bisphosphate-independent manner. J Biol Chem. 2019;294:5632\u201342.","journal-title":"J Biol Chem"},{"key":"3201_CR32","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1046\/j.1471-4159.2003.01793.x","volume":"85","author":"AM Kocabas","year":"2003","unstructured":"Kocabas AM, Rudnick G, Kilic F. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters. J Neurochem. 2003;85:1513\u201320.","journal-title":"J Neurochem"},{"key":"3201_CR33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/jnc.15145","volume":"157","author":"K Jayaraman","year":"2021","unstructured":"Jayaraman K, Das AK, Luethi D, Sz\u00f6ll\u0151si D, Sch\u00fctz GJ, Reith MEA, et al. SLC6 transporter oligomerization. J Neurochem. 2021;157:919\u201329.","journal-title":"J Neurochem"},{"key":"3201_CR34","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s42003-022-04210-1","volume":"5","author":"D Luethi","year":"2022","unstructured":"Luethi D, Maier J, Rudin D, Sz\u00f6ll\u0151si D, Angenoorth TJF, Stankovic S, et al. Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux. Commun Biol. 2022;5:1259.","journal-title":"Commun Biol"},{"key":"3201_CR35","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1074\/jbc.M201926200","volume":"278","author":"GE Torres","year":"2003","unstructured":"Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao WD, et al. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem. 2003;278:2731\u20139.","journal-title":"J Biol Chem"},{"key":"3201_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1124\/mi.4.1.38","volume":"4","author":"HH Sitte","year":"2004","unstructured":"Sitte HH, Farhan H, Javitch JA. Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. Mol Interv. 2004;4:38\u201347.","journal-title":"Mol Interv"},{"key":"3201_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1124\/mol.67.1.140","volume":"67","author":"S Seidel","year":"2005","unstructured":"Seidel S, Singer EA, Just H, Farhan H, Scholze P, Kudlacek O, et al. Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol. 2005;67:140\u201351.","journal-title":"Mol Pharmacol"},{"key":"3201_CR38","doi-asserted-by":"publisher","first-page":"11642","DOI":"10.1073\/pnas.1220552110","volume":"110","author":"F Buchmayer","year":"2013","unstructured":"Buchmayer F, Schicker K, Steinkellner T, Geier P, St\u00fcbiger G, Hamilton PJ, et al. Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate. Proc Natl Acad Sci USA. 2013;110:11642\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3201_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nchembio.1545","volume":"10","author":"PJ Hamilton","year":"2014","unstructured":"Hamilton PJ, Belovich AN, Khelashvili G, Saunders C, Erreger K, Javitch JA, et al. PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein. Nat Chem Biol. 2014;10:582\u20139.","journal-title":"Nat Chem Biol"},{"key":"3201_CR40","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1038\/s41380-019-0620-0","volume":"26","author":"AN Belovich","year":"2021","unstructured":"Belovich AN, Aguilar JI, Mabry SJ, Cheng MH, Zanella D, Hamilton PJ, et al. A network of phosphatidylinositol (4,5)-bisphosphate (PIP(2)) binding sites on the dopamine transporter regulates amphetamine behavior in Drosophila Melanogaster. Mol Psychiatry. 2021;26:4417\u201330.","journal-title":"Mol Psychiatry"},{"key":"3201_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14089","volume":"8","author":"A Anderluh","year":"2017","unstructured":"Anderluh A, Hofmaier T, Klotzsch E, Kudlacek O, Stockner T, Sitte HH, et al. Direct PIP2 binding mediates stable oligomer formation of the serotonin transporter. Nature Communications. 2017;8:14089.","journal-title":"Nature Communications"},{"key":"3201_CR42","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1007\/s00018-010-0432-5","volume":"67","author":"K Kwiatkowska","year":"2010","unstructured":"Kwiatkowska K. One lipid, multiple functions: how various pools of PI(4,5)P(2) are created in the plasma membrane. Cell Mol Life Sci. 2010;67:3927\u201346.","journal-title":"Cell Mol Life Sci"},{"key":"3201_CR43","doi-asserted-by":"publisher","first-page":"29489","DOI":"10.1074\/jbc.M109.038034","volume":"284","author":"M Hao","year":"2009","unstructured":"Hao M, Bogan JS. Cholesterol regulates glucose-stimulated insulin secretion through phosphatidylinositol 4,5-bisphosphate. J Biol Chem. 2009;284:29489\u201398.","journal-title":"J Biol Chem"},{"key":"3201_CR44","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/0884533611411306","volume":"26","author":"MM Perica","year":"2011","unstructured":"Perica MM, Delas I. Essential fatty acids and psychiatric disorders. Nutr Clin Pract. 2011;26:409\u201325.","journal-title":"Nutr Clin Pract"},{"key":"3201_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0924-977X(03)00099-3","volume":"14","author":"GI Papakostas","year":"2004","unstructured":"Papakostas GI, Ong\u00fcr D, Iosifescu DV, Mischoulon D, Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol. 2004;14:135\u201342.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3201_CR46","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1176\/appi.ajp.2011.11010160","volume":"168","author":"OD Howes","year":"2011","unstructured":"Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry. 2011;168:1311\u20137.","journal-title":"Am J Psychiatry"},{"key":"3201_CR47","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/syn.20648","volume":"63","author":"FJ Lee","year":"2009","unstructured":"Lee FJ, Pei L, Liu F. Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia. Synapse. 2009;63:710\u20132.","journal-title":"Synapse"},{"key":"3201_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.encep.2018.05.001","volume":"44","author":"L Tritschler","year":"2018","unstructured":"Tritschler L, Gaillard R, Gardier AM, David DJ, Guilloux JP. Consequences of the monoaminergic systems cross-talk in the antidepressant activity]. Encephale. 2018;44:264\u201373.","journal-title":"Encephale"},{"key":"3201_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/164_2021_446","volume":"266","author":"LS Vieira","year":"2021","unstructured":"Vieira LS, Wang J. Brain plasma membrane monoamine transporter in health and disease. Handb Exp Pharmacol. 2021;266:253\u201380.","journal-title":"Handb Exp Pharmacol"},{"key":"3201_CR50","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1523\/JNEUROSCI.0473-08.2008","volume":"28","author":"MS Mazei-Robison","year":"2008","unstructured":"Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, et al. Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci. 2008;28:7040\u20136.","journal-title":"J Neurosci"},{"key":"3201_CR51","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.82641","volume":"12","author":"S Bhat","year":"2023","unstructured":"Bhat S, El-Kasaby A, Kasture A, Boytsov D, Reichelt JB, Hummel T, et al. A mechanism of uncompetitive inhibition of the serotonin transporter. eLife. 2023;12:e82641.","journal-title":"eLife"},{"key":"3201_CR52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114204120","volume":"120","author":"M Niello","year":"2023","unstructured":"Niello M, Sideromenos S, Gradisch R, Shea RO, Schwazer J, Maier J, et al. Persistent binding at dopamine transporters determines sustained psychostimulant effects. Proc Natl Acad Sci USA. 2023;120:e2114204120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3201_CR53","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41386-021-01221-0","volume":"47","author":"D Rudin","year":"2022","unstructured":"Rudin D, McCorvy JD, Glatfelter GC, Luethi D, Sz\u00f6ll\u0151si D, Ljubi\u0161i\u0107 T, et al. (2-Aminopropyl)benzo[\u03b2]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice. Neuropsychopharmacology. 2022;47:914\u201323.","journal-title":"Neuropsychopharmacology"},{"key":"3201_CR54","doi-asserted-by":"publisher","first-page":"18524","DOI":"10.1074\/jbc.M112.343681","volume":"287","author":"S Bulling","year":"2012","unstructured":"Bulling S, Schicker K, Zhang YW, Steinkellner T, Stockner T, Gruber CW, et al. The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. J Biol Chem. 2012;287:18524\u201334.","journal-title":"J Biol Chem"},{"key":"3201_CR55","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1074\/jbc.M111.304261","volume":"287","author":"K Schicker","year":"2012","unstructured":"Schicker K, Uzelac Z, Gesmonde J, Bulling S, Stockner T, Freissmuth M, et al. Unifying concept of serotonin transporter-associated currents. J Biol Chem. 2012;287:438\u201345.","journal-title":"J Biol Chem"},{"key":"3201_CR56","doi-asserted-by":"publisher","first-page":"e67996","DOI":"10.7554\/eLife.67996","volume":"10","author":"S Bhat","year":"2021","unstructured":"Bhat S, Niello M, Schicker K, Pifl C, Sitte HH, Freissmuth M, et al. Handling of intracellular K(+) determines voltage dependence of plasmalemmal monoamine transporter function. Elife. 2021;10:e67996.","journal-title":"Elife"},{"key":"3201_CR57","doi-asserted-by":"publisher","first-page":"13439","DOI":"10.1074\/jbc.M511382200","volume":"281","author":"VM Korkhov","year":"2006","unstructured":"Korkhov VM, Holy M, Freissmuth M, Sitte HH. The conserved glutamate (Glu136) in transmembrane domain 2 of the serotonin transporter is required for the conformational switch in the transport cycle*. Journal of Biological Chemistry. 2006;281:13439\u201348.","journal-title":"Journal of Biological Chemistry"},{"key":"3201_CR58","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1074\/jbc.M800622200","volume":"283","author":"I Bartholom\u00e4us","year":"2008","unstructured":"Bartholom\u00e4us I, Milan-Lobo L, Nicke A, Dutertre S, Hastrup H, Jha A, et al. Glycine transporter dimers: evidence for occurrence in the plasma membrane. J Biol Chem. 2008;283:10978\u201391.","journal-title":"J Biol Chem"},{"key":"3201_CR59","doi-asserted-by":"publisher","first-page":"47254","DOI":"10.1074\/jbc.M408154200","volume":"279","author":"S W\u00fcller","year":"2004","unstructured":"W\u00fcller S, Wiesner B, L\u00f6ffler A, Furkert J, Krause G, Hermosilla R, et al. Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors*. J Biol Chem. 2004;279:47254\u201363.","journal-title":"J Biol Chem"},{"key":"3201_CR60","doi-asserted-by":"publisher","DOI":"10.1063\/1.2158031","volume":"87","author":"M Moertelmaier","year":"2005","unstructured":"Moertelmaier M, Brameshuber M, Linimeier M, Sch\u00fctz GJ, Stockinger H. Thinning out clusters while conserving stoichiometry of labeling. Appl Phys Lett. 2005;87:263903.","journal-title":"Appl Phys Lett"},{"key":"3201_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nmeth.2368","volume":"10","author":"JJ Hulce","year":"2013","unstructured":"Hulce JJ, Cognetta AB, Niphakis MJ, Tully SE, Cravatt BF. Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells. Nat Methods. 2013;10:259\u201364.","journal-title":"Nat Methods"},{"key":"3201_CR62","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.1074\/jbc.M109.083154","volume":"285","author":"S Sucic","year":"2010","unstructured":"Sucic S, Dallinger S, Zdrazil B, Weissensteiner R, J\u00f8rgensen TN, Holy M, et al. The N terminus of monoamine transporters is a lever required for the action of amphetamines. J Biol Chem. 2010;285:10924\u201338.","journal-title":"J Biol Chem"},{"key":"3201_CR63","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jnc.12007","volume":"123","author":"KT Jones","year":"2012","unstructured":"Jones KT, Zhen J, Reith ME. Importance of cholesterol in dopamine transporter function. J Neurochem. 2012;123:700\u201315.","journal-title":"J Neurochem"},{"key":"3201_CR64","doi-asserted-by":"publisher","first-page":"7747","DOI":"10.1074\/jbc.M114.573477","volume":"290","author":"H Bjerregaard","year":"2015","unstructured":"Bjerregaard H, Severinsen K, Said S, Wiborg O, Sinning S. A dualistic conformational response to substrate binding in the human serotonin transporter reveals a high affinity state for serotonin. J Biol Chem. 2015;290:7747\u201355.","journal-title":"J Biol Chem"},{"key":"3201_CR65","doi-asserted-by":"publisher","first-page":"9706","DOI":"10.1073\/pnas.160170397","volume":"97","author":"C Grewer","year":"2000","unstructured":"Grewer C, Watzke N, Wiessner M, Rauen T. Glutamate translocation of the neuronal glutamate transporter EAAC1 occurs within milliseconds. Proc Natl Acad Sci USA. 2000;97:9706\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3201_CR66","doi-asserted-by":"publisher","first-page":"25864","DOI":"10.1074\/jbc.M116.753319","volume":"291","author":"PS Hasenhuetl","year":"2016","unstructured":"Hasenhuetl PS, Freissmuth M, Sandtner W. Electrogenic binding of intracellular cations defines a kinetic decision point in the transport cycle of the human serotonin transporter. J Biol Chem. 2016;291:25864\u201376.","journal-title":"J Biol Chem"},{"key":"3201_CR67","doi-asserted-by":"publisher","first-page":"28274","DOI":"10.1074\/jbc.M210652200","volume":"278","author":"T Sorkina","year":"2003","unstructured":"Sorkina T, Doolen S, Galperin E, Zahniser NR, Sorkin A. Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J Biol Chem. 2003;278:28274\u201383.","journal-title":"J Biol Chem"},{"key":"3201_CR68","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1074\/jbc.274.8.4876","volume":"274","author":"JL Berfield","year":"1999","unstructured":"Berfield JL, Wang LC, Reith ME. Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species? J Biol Chem. 1999;274:4876\u201382.","journal-title":"J Biol Chem"},{"key":"3201_CR69","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0304-3940(01)02058-4","volume":"309","author":"P Scholze","year":"2001","unstructured":"Scholze P, Sitte HH, Singer EA. Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters. Neurosci Lett. 2001;309:173\u20136.","journal-title":"Neurosci Lett"},{"key":"3201_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl3857","volume":"7","author":"D Yang","year":"2021","unstructured":"Yang D, Gouaux E. Illumination of serotonin transporter mechanism and role of the allosteric site. Sci Adv. 2021;7:eabl3857.","journal-title":"Sci Adv"},{"key":"3201_CR71","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-024-07739-9","volume":"632","author":"DK Srivastava","year":"2024","unstructured":"Srivastava DK, Navratna V, Tosh DK, Chinn A, Sk MF, Tajkhorshid E, et al. Structure of the human dopamine transporter and mechanisms of inhibition. Nature. 2024;632:672\u20137.","journal-title":"Nature"},{"key":"3201_CR72","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.bpj.2023.04.021","volume":"122","author":"C Bodner","year":"2023","unstructured":"Bodner C, Kiesenhofer D, Sch\u00fctz GJ, Brameshuber M. Monte Carlo simulations for the evaluation of oligomerization data in TOCCSL experiments. Biophys J. 2023;122:2367\u201380.","journal-title":"Biophys J"},{"key":"3201_CR73","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature10737","volume":"481","author":"H Krishnamurthy","year":"2012","unstructured":"Krishnamurthy H, Gouaux E. X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature. 2012;481:469\u201374.","journal-title":"Nature"},{"key":"3201_CR74","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nsmb.2816","volume":"21","author":"K Kazmier","year":"2014","unstructured":"Kazmier K, Sharma S, Quick M, Islam SM, Roux B, Weinstein H, et al. Conformational dynamics of ligand-dependent alternating access in LeuT. Nat Struct Mol Biol. 2014;21:472\u20139.","journal-title":"Nat Struct Mol Biol"},{"key":"3201_CR75","doi-asserted-by":"publisher","first-page":"e1006229","DOI":"10.1371\/journal.pcbi.1006229","volume":"14","author":"K Jayaraman","year":"2018","unstructured":"Jayaraman K, Morley AN, Sz\u00f6ll\u0151si D, Wassenaar TA, Sitte HH, Stockner T. Dopamine transporter oligomerization involves the scaffold domain, but spares the bundle domain. PLoS Comput Biol. 2018;14:e1006229.","journal-title":"PLoS Comput Biol"},{"key":"3201_CR76","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","volume":"60","author":"FW Pfrieger","year":"2003","unstructured":"Pfrieger FW. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci. 2003;60:1158\u201371.","journal-title":"Cell Mol Life Sci"},{"key":"3201_CR77","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jns.2004.11.036","volume":"229\u2013230","author":"AR Koudinov","year":"2005","unstructured":"Koudinov AR, Koudinova NV. Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. J Neurol Sci. 2005;229\u2013230:233\u201340.","journal-title":"J Neurol Sci"},{"key":"3201_CR78","first-page":"539","volume":"6","author":"J Rabe-Jab\u0142o\u0144ska","year":"2000","unstructured":"Rabe-Jab\u0142o\u0144ska J, Poprawska I. Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission. Med Sci Monit. 2000;6:539\u201347.","journal-title":"Med Sci Monit"},{"key":"3201_CR79","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1021\/pr800188y","volume":"7","author":"E Schwarz","year":"2008","unstructured":"Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D, et al. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J Proteome Res. 2008;7:4266\u201377.","journal-title":"J Proteome Res"},{"key":"3201_CR80","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1054\/plef.1999.0037","volume":"60","author":"DF Horrobin","year":"1999","unstructured":"Horrobin DF, Bennett CN. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids. 1999;60:217\u201334.","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"key":"3201_CR81","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jad.2014.04.015","volume":"164","author":"JA Schwartz","year":"2014","unstructured":"Schwartz JA, Rowland MW, Beaver KM. A genetically informed test of cholesterol levels and self-control, depressive symptoms, antisocial behavior, and neuroticism. J Affect Disord. 2014;164:139\u201347.","journal-title":"J Affect Disord"},{"key":"3201_CR82","first-page":"270","volume":"19","author":"M Jakovljevi\u0107","year":"2007","unstructured":"Jakovljevi\u0107 M, Reiner Z, Milici\u0107 D. Mental disorders, treatment response, mortality and serum cholesterol: a new holistic look at old data. Psychiatr Danub. 2007;19:270\u201381.","journal-title":"Psychiatr Danub"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03201-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:02:35Z","timestamp":1768849355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03201-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3201"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03201-y","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted solely using in vitro experiments on cultured cells. No human participants or animal subjects were involved; therefore, ethics approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}